Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

ARNA 4.88 +0.04 (0.83%)
price chart
Arena Pharmaceuticals Inc. Still Down After CEO's Sale
"Week-over-week prescriptions are increasing. We're very excited about that. And we expect those prescriptions to continue to increase as, yet a larger salesforce, goes into the field in the next few weeks.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Sells Marketing And Distribution ...
Dallas, Texas 07/22/2014 (ustradevoice) - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)'s wholly owned subsidiary Arena Pharmaceuticals GmbH has undertaken a marketing and supply deal for BELVIQ� with Abic Marketing Limited, the local Israel-based ...
Why Arena Pharmaceuticals (ARNA) Stock Is Dropping Today
NEW YORK (TheStreet) -- Arena Pharmaceuticals (ARNA_) shares are plummeting, down -8.1% to $5.37, on Monday after CEO Jack Lief sold 223,525 shares of the company at an average price $5.85 for a total transaction of $1,307,621.25, according to an ...
Arena Stock Takes A Tumble � CEO Sells Shares, Investor Confidence Falls  Bidness Etc
Arena chief's stock sale invites criticism (ARNA)  Seeking Alpha
Related articles »  
Eye-Catching Stocks � Arena Pharmaceuticals, Inc.(NASDAQ:ARNA), EXCO ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) decreased -0.58% at the price of $4.85 recently on a traded volume of 1.84 million shares, in comparison to 5.63 million shares of average trading volume.
Mid-Day Buzzers � Arena Pharmaceuticals, Inc. (NASDAQ:ARNA),Himax ...
Las Vegas, NV - 23 July, 2014 - (TechSonian) - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) declared that its wholly owned subsidiary, Arena Pharmaceuticals GmbH, has entered into an exclusive marketing and supply agreement for BELVIQ� ...
Related articles »  
News Recap: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Geron Corporation ...
Lakeway, NY - (MARKET NEWS CALL) - 7/22/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Morning Alert -Arena Pharmaceuticals, Inc. (ARNA, Office Depot Inc (ODP ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) declared that its wholly owned subsidiary, Arena Pharmaceuticals GmbH, has entered into an exclusive marketing and supply agreement for BELVIQ� (lorcaserin HCl) with Teva Pharmaceutical Industries ...
Arena Pharmaceuticals Pain Candidate Gets New U.S. Patent
The U.S. Patent and Trademark Office issued a new patent to Arena Pharmaceuticals, Inc. (ARNA - Snapshot Report) for its pain candidate APD371 (U.
Arena Gives Pipeline Exposure - Is The Company Partner Shopping? (ARNA)  Seeking Alpha
Related articles »  
How Biotech Stocks React on News- Arena Pharmaceuticals, Inc. (NASDAQ ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) [Trend Analysis] reported that its wholly owned subsidiary, Arena Pharmaceuticals, has signed into an exclusive marketing and supply contract for BELVIQ with Teva Pharmaceutical Industries Limited's (TEVA) ...
Big Movers: VIVUS, Inc. (NASDAQ:VVUS), Arena Pharmaceuticals, Inc ...  Markets Insider
News Recap: MannKind Corporation (NASDAQ:MNKD), Geron Corporation ...  Market News Call
Related articles »  
Morning Alert-Arena Pharmaceuticals, Inc. (Nasdaq :ARNA) ,Ariad ...
Las Vegas, NV - July 22, 2014 - (TechSonian) �Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) declared that it will report its second quarter 2014 financial results on Wednesday, August 6, 2014, before the market opens.
Related articles »